Clinical Trial Update: Ketamine and Epigenetic Aging [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update exploring ketamine and epigenetic aging for depression and PTSD.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder
• Post-traumatic Stress Disorder

Drugs mentioned

• Ketamine (ketamine)

Snippet

Sponsor: TruDiagnostic | Conditions: Depression, Post Traumatic Stress Disorder | Phase 2 | Status: UNKNOWN